India to Philippines: Clindamycin Export Trade Route
India has recorded 163 verified shipments of Clindamycin exported to Philippines, representing a combined trade value of $3.7M USD. This corridor is served by 37 active Indian exporters, with an average shipment value of $22.4K USD. The leading Indian exporter is BDH INDUSTRIES LIMITED, which accounts for 57% of total export value with 2 shipments worth $2.1M USD. On the buying side, NELPA LIFESCIENCES INC is the largest importer in Philippines with $2.1M USD in purchases. The top 3 suppliers — BDH INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, FLAMINGO PHARMACEUTICALS LIMITED — together control 75% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Clindamycin corridor is one of India's established pharmaceutical export routes, with 163 shipments documented worth a combined $3.7M USD. The route is dominated by BDH INDUSTRIES LIMITED, which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.
Across 37 active suppliers, the average shipment value stands at $22.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #19 among India's top clindamycin export destinations globally.
On the import side, key buyers of Indian clindamycin in Philippines include NELPA LIFESCIENCES INC, HHC 12TH FLOOR, TRIPLE TACT IMPORT AND EXPORT CORP and 44 others. NELPA LIFESCIENCES INC is the single largest importer with 4 shipments valued at $2.1M USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#19
- Annual growth+21.6%
- Demand growth+20.2%
- Regulatory ease80/100
Top 10 Indian Clindamycin Exporters to Philippines
Showing top 10 of 37 Indian suppliers exporting Clindamycin to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BDH INDUSTRIES LIMITED Avg $1.0M per shipment | 2 | $2.1M | 56.5% |
| 2 | UNITED BIOTECH PRIVATE LIMITED Avg $10.3K per shipment | 35 | $361.0K | 9.9% |
| 3 | FLAMINGO PHARMACEUTICALS LIMITED Avg $15.0K per shipment | 20 | $299.1K | 8.2% |
| 4 | UNITED BIOTECH PRIVATE LIMITED Avg $12.6K per shipment | 9 | $113.7K | 3.1% |
| 5 | KILITCH DRUGS (INDIA) LIMITED. Avg $36.3K per shipment | 3 | $109.0K | 3.0% |
| 6 | KILITCH DRUGS INDIA LIMITED Avg $72.8K per shipment | 1 | $72.8K | 2.0% |
| 7 | SHREEJI IMPEX Avg $22.4K per shipment | 3 | $67.3K | 1.8% |
| 8 | XL LABORATORIES PRIVATE LIMITED Avg $11.3K per shipment | 5 | $56.7K | 1.6% |
| 9 | BDH HEALTHCARE PRIVATE LIMITED Avg $25.9K per shipment | 2 | $51.8K | 1.4% |
| 10 | KWALITY PHARMACEUTICALS LIMITED Avg $3.7K per shipment | 13 | $48.3K | 1.3% |
This table shows the top 10 of 37 Indian companies exporting clindamycin to Philippines, ranked by total trade value. The listed exporters are: BDH INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, FLAMINGO PHARMACEUTICALS LIMITED, UNITED BIOTECH PRIVATE LIMITED , KILITCH DRUGS (INDIA) LIMITED., KILITCH DRUGS INDIA LIMITED, SHREEJI IMPEX, XL LABORATORIES PRIVATE LIMITED , BDH HEALTHCARE PRIVATE LIMITED, KWALITY PHARMACEUTICALS LIMITED. BDH INDUSTRIES LIMITED is the dominant supplier with 2 shipments worth $2.1M USD, giving it a 57% market share. The top 3 suppliers together account for 75% of the total trade value on this route.
Showing top 10 of 37 total Indian exporters on the India to Philippines Clindamycin export route.
Top 10 Clindamycin Importers in Philippines
Showing top 10 of 47 known buyers in Philippines receiving Clindamycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian clindamycin in Philippines include NELPA LIFESCIENCES INC, HHC 12TH FLOOR, TRIPLE TACT IMPORT AND EXPORT CORP, TRIPLE TACT IMPORT AND EXPORT CROP, H H C, among 47 total buyers. The largest importer is NELPA LIFESCIENCES INC, accounting for $2.1M USD across 4 shipments — representing 58% of all clindamycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NELPA LIFESCIENCES INC | 4 | $2.1M | 58.0% |
| 2 | HHC 12TH FLOOR | 2 | $152.8K | 4.2% |
| 3 | TRIPLE TACT IMPORT AND EXPORT CORP | 16 | $144.4K | 4.0% |
| 4 | TRIPLE TACT IMPORT AND EXPORT CROP | 10 | $144.0K | 3.9% |
| 5 | H H C | 11 | $130.7K | 3.6% |
| 6 | TO THE ORDER OF | 3 | $109.0K | 3.0% |
| 7 | INDIAN OVERSEAS BANK | 1 | $72.8K | 2.0% |
| 8 | TRIPLE TACT IMPORT AND EXPORT CROP. | 9 | $72.7K | 2.0% |
| 9 | TRIPLE TACT IMPORT AND EXPORT CORP | 6 | $71.5K | 2.0% |
| 10 | NELPA LIFESCIENCES INC, NO.5 KM. 18 | 3 | $67.3K | 1.8% |
Showing top 10 of 47 Clindamycin importers in Philippines on this route.
Top 10 Clindamycin Formulations Imported by Philippines
Showing top 10 of 132 product formulations shipped on the India to Philippines Clindamycin route, ranked by trade value
Philippines imports a wide range of clindamycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, CLINDASAPH-150(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 150 MG)(PAC OF 10X10 C) — accounts for $1.7M USD across 1 shipments. There are 132 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, CLINDASAPH-150(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 150 MG)(PAC OF 10X10 C) | 1 | $1.7M | 45.8% |
| 2 | PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE, CLINDASAPH-300(CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 300 MG)(PAC OF 10X10 C) | 1 | $391.3K | 10.7% |
| 3 | CLINDAMYCIN 300MG CAPSULE ACRESIL 300 10X10-BLISTER GREEN CARD NO.21168 VALID UPTO 31.03.2027 | 1 | $152.8K | 4.2% |
| 4 | PHARMACEUTICAL PRODUCTS- CLINDASAPH-600(CLINDAMYCIN PHOSPHATE 150 MG/ML SOLUTION FOR INJECTION USP) | 1 | $72.9K | 2.0% |
| 5 | PHARMACEUTICAL PRODUCTS- CLINDASAPH-600CLINDAMYCIN PHOSPHATE 150 MG/ML SOLUTION FOR INJECTION USP | 1 | $72.8K | 2.0% |
| 6 | PHARMACEUTICAL PRODUCTS-HARMLESS MEDICINE CLINDASAPH-300 (CLINDAMYCIN HYDROCHLORIDE CAPSULES USP 300 MG) | 3 | $67.3K | 1.8% |
| 7 | CLINDAMYCIN CAPSULES 300MG CLIMAXIN 10X | 1 | $33.6K | 0.9% |
| 8 | CLINDAMYCIN CAPSULES 300MG-CLIMAXIN 10X10-BLISTER GREEN CARD NO.21168 VALID UPTO 31.03.2027 | 1 | $33.3K | 0.9% |
| 9 | PHARMACEUTICAL PRODUCTS FOR HUMAN USE, HARMLESS MEDICINES:CLINDAMYCIN CAPSULES BP 300MG CLINDANOVA AS PER INVOICE | 1 | $32.8K | 0.9% |
| 10 | CLINDAMYCIN 300MG CAPSULE POTECIN 10X | 2 | $31.8K | 0.9% |
Showing top 10 of 132 Clindamycin formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 24 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's clindamycin exports to Philippines are driven primarily by a handful of large-scale manufacturers. BDH INDUSTRIES LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 37 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — BDH INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, FLAMINGO PHARMACEUTICALS LIMITED — together account for 75% of total trade value on this route. The average shipment value of $22.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, clindasaph-300(clindamycin hydrochloride capsules usp 300 mg)(pac of 10x10 c) and clindamycin 300mg capsule acresil 300 10x10-blister green card no.21168 valid upto 31.03.2027, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NELPA LIFESCIENCES INC is the largest importer with 4 shipments worth $2.1M USD — representing 58% of all clindamycin imports from India on this route. A total of 47 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.7M
- Avg. Shipment
- $22.4K
- Suppliers
- 37
- Buyers
- 47
- Transit (Sea)
- ~33 days
- Annual Growth
- +21.6%
Related Analysis
Other Clindamycin Routes
Unlock the Full India to Philippines Clindamycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 163 shipments on this route.
Frequently Asked Questions — India to Philippines Clindamycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Clindamycin to Philippines?
The leading Indian exporters of Clindamycin to Philippines are BDH INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, FLAMINGO PHARMACEUTICALS LIMITED. BDH INDUSTRIES LIMITED holds the largest market share at approximately 57% of total trade value on this route.
Q What is the total value of Clindamycin exports from India to Philippines?
India exports Clindamycin to Philippines worth approximately $3.7M USD across 163 recorded shipments. The average value per shipment is $22.4K USD.
Q Which ports does India use to ship Clindamycin to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 24 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Philippines for Clindamycin?
The average transit time for Clindamycin shipments from India to Philippines is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Clindamycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.6% with demand growth tracking at 20.2%. The route is ranked #19 among India's top Clindamycin export destinations globally.
Q How many suppliers are active on the India to Philippines Clindamycin route?
There are currently 37 active Indian suppliers exporting Clindamycin to Philippines. The market is moderately concentrated with BDH INDUSTRIES LIMITED accounting for 57% of total shipment value.
Q Who are the main importers of Clindamycin from India in Philippines?
The leading importers of Indian Clindamycin in Philippines include NELPA LIFESCIENCES INC, HHC 12TH FLOOR, TRIPLE TACT IMPORT AND EXPORT CORP, TRIPLE TACT IMPORT AND EXPORT CROP, H H C. NELPA LIFESCIENCES INC is the largest buyer with 4 shipments worth $2.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Clindamycin.
- 2.Supplier/Buyer Matching: 37 Indian exporters and 47 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 163 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
163 Verified Shipments
37 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists